Immunity to SARS-CoV-2 variants of concern

Science. 2021 Mar 12;371(6534):1103-1104. doi: 10.1126/science.abg7404.

Authors

Daniel M Altmann¹, Rosemary J Boyton^{2

3}, Rupert Beale^{4

5}

Affiliations

¹ Department of Immunology and Inflammation, Imperial College London, UK. d.altmann@imperial.ac.uk.
² Department of Infectious Disease, Imperial College London, UK.
³ Lung Division, Royal Brompton and Harefield Hospitals, London, UK.
⁴ The Francis Crick Institute, London, UK.
⁵ Division of Medicine, University College London, London, UK.

PMID: 33707254
DOI: 10.1126/science.abg7404

No abstract available

Publication types

Comment

MeSH terms

BNT162 Vaccine
COVID-19 Vaccines
COVID-19*
Humans
SARS-CoV-2
Vaccines*

Substances

COVID-19 Vaccines
Vaccines
BNT162 Vaccine

Grants and funding